Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (891-900 of 993) with videos related to

Pageof 100
Sort By:
Annals of Surgical Oncology|December 3, 2025
The Effect of Pelvic Lymph Node Dissection on Cancer-Specific Mortality in Partial Cystectomy According to Eligibility CriteriaMattia Longoni, Quynh Chi Le, Fabian Falkenbach, et al.
Urologic Oncology|February 22, 2025
Sex-related differences in response to neoadjuvant and adjuvant chemotherapy in urothelial carcinoma of urinary bladder treated with radical cystectomyMario de Angelis, Carolin Siech, Letizia Maria Ippolita Jannello, et al.
Journal of Racial and Ethnic Health Disparities|March 4, 2025
Effect of Race/Ethnicity on In-hospital Outcomes After Radical CystectomyNatali Rodriguez Peñaranda, Francesco Di Bello, Fabian Falkenbach, et al.
European Urology|March 15, 2024
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective StudyManuel Weber, Wolfgang P Fendler, Aravind S Ravi Kumar, et al.
Urology|March 8, 2025
Survival Outcomes and Temporal Trends of Non-Surgical Management Vs Radical Cystectomy in Non-Organ-Confined Urothelial Bladder CancerMattia Longoni, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2022
Olaparib tolerability and common adverse-event management in patients with metastatic castration-resistant prostate cancer: Further analyses from the PROfound studyGuilhem Roubaud, Mustafa Özgüroğlu, Nicolas Penel, et al.
International Journal of Cancer|July 3, 2024
Contemporary survival in metastatic bladder cancer patients: A population-based studyFrancesco Di Bello, Carolin Siech, Letizia Maria Ippolita Jannello, et al.
European Urology Open Science|July 13, 2023
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell CarcinomaMattia L Piccinelli, Stefano Tappero, Cristina Cano Garcia, et al.
The Prostate|March 20, 2024
Other-cause mortality in incidental prostate cancerFrancesco Di Bello, Andrea Baudo, Mario de Angelis, et al.
World Journal of Urology|September 27, 2023
Regional differences in clear cell metastatic renal cell carcinoma patients across the USALukas Scheipner, Stefano Tappero, Mattia Luca Piccinelli, et al.
Pageof 100

Showing results (891-900 of 993) with videos related to

Sort By:
Pageof 100
Annals of Surgical Oncology|December 3, 2025
The Effect of Pelvic Lymph Node Dissection on Cancer-Specific Mortality in Partial Cystectomy According to Eligibility CriteriaMattia Longoni, Quynh Chi Le, Fabian Falkenbach, et al.
Urologic Oncology|February 22, 2025
Sex-related differences in response to neoadjuvant and adjuvant chemotherapy in urothelial carcinoma of urinary bladder treated with radical cystectomyMario de Angelis, Carolin Siech, Letizia Maria Ippolita Jannello, et al.
Journal of Racial and Ethnic Health Disparities|March 4, 2025
Effect of Race/Ethnicity on In-hospital Outcomes After Radical CystectomyNatali Rodriguez Peñaranda, Francesco Di Bello, Fabian Falkenbach, et al.
European Urology|March 15, 2024
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective StudyManuel Weber, Wolfgang P Fendler, Aravind S Ravi Kumar, et al.
Urology|March 8, 2025
Survival Outcomes and Temporal Trends of Non-Surgical Management Vs Radical Cystectomy in Non-Organ-Confined Urothelial Bladder CancerMattia Longoni, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2022
Olaparib tolerability and common adverse-event management in patients with metastatic castration-resistant prostate cancer: Further analyses from the PROfound studyGuilhem Roubaud, Mustafa Özgüroğlu, Nicolas Penel, et al.
International Journal of Cancer|July 3, 2024
Contemporary survival in metastatic bladder cancer patients: A population-based studyFrancesco Di Bello, Carolin Siech, Letizia Maria Ippolita Jannello, et al.
European Urology Open Science|July 13, 2023
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell CarcinomaMattia L Piccinelli, Stefano Tappero, Cristina Cano Garcia, et al.
The Prostate|March 20, 2024
Other-cause mortality in incidental prostate cancerFrancesco Di Bello, Andrea Baudo, Mario de Angelis, et al.
World Journal of Urology|September 27, 2023
Regional differences in clear cell metastatic renal cell carcinoma patients across the USALukas Scheipner, Stefano Tappero, Mattia Luca Piccinelli, et al.
Pageof 100